Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib as First-Line Therapy in Chinese Patients with Metastatic RCC
NCT00706706Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jul 2008
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sunitinib in renal cell carcinoma (RCC), sponsored by Pfizer. Started Jul 2008; status: completed.
02
Drugs
sunitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00706706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00706706.